GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
2.1k
c/compounding·posted 12 months ago by u/priya_palacios

telehealth is the most under-discussed thing in c/progresspics

Discussion Long Haul ×6 Slow Clap ×1

Week 68 update. 19kg down from the start, early fullness basically gone since about week 25.

Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with early fullness.

The part that surprised me is how much of this is admin. Ordering, storing, logging, remembering. Nobody mentions that the hard bit is not the drug, it is the routine.

Happy to answer anything. Please do not ask me what dose you should be on.

2,277 up / 200 down92% upvoted44 commentsid jqug333 Aug 2025

44 comments

30 in this archive, depth 5

best — the order this archive was captured in

u/tb500_tangent0 points·12 months ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/niels_roos1 point·11 months ago

the shortage list is temporary, it ends and compounding becomes illegal again

Yes, exactly this, and it is the bit that took me 51 weeks to accept.

replysharereportpermalink
u/mateusz_adebayo127 points·12 months ago

API source questions are on-topic and compounders dodging them is newsworthy

replysharereportpermalink
u/formulary_fighterMOD64 points·11 months ago·edited

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/lipid_panel_larrybloodwork121 points·11 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/ferran_mensah32 points·11 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/gallbladder_gary25 points·11 months ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/fatima_kowalski36 points·11 months ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/camila_sandvik89 points·11 months ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/priya_palaciosOP56 points·11 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/sofia_nascimento27 points·11 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/bilal_osei23 points·11 months ago

state board rules differ, say which state

replysharereportpermalink
u/tobias_vukovic18 points·11 months ago

Not to be pedantic but shortage list and telehealth are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/jonas_eriksen31 points·11 months ago

Did they tell you their API source or dodge the question?

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/rafael_ostergaard25 points·11 months ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/ferran_mensah-23 points·11 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/ahmed_okafor28 points·11 months ago·edited

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/incretin_ivypharmacology68 points·11 months ago

The telehealth + compounding combo cost telehealth plus 18% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/ismael_pires64 points·11 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
u/hassan_chowdhury29 points·11 months ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/priya_palaciosOP17 points·11 months ago

the the UK situation is different from the US, different regulations

replysharereportpermalink
load more comments (4) →
u/anya_antonsen53 points·11 months ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/swirl_dont_shakereconstitution17 points·11 months ago·edited

the the UK situation is different from the US, different regulations

replysharereportpermalink
load more comments (1) →
u/rania_diallo27 points·12 months ago

Asked 12 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

replysharereportpermalink
u/marit_laurent39 points·12 months ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.